To conduct end-to-end Bioequivalence studies
Jeevan Scientific Technology announced that the Company's Clinical Pharmacology Centre to conduct Bioavailability/Bioequivalence studies has been approved by the Office of Drug Control General, India (DCGI) on 16 December 2016 for a period of Three (3) years.This Centre having four independent clinics having a total capacity of 132 beds will facilitate end-to-end Bioequivalence studies by Jeevan Scientific Technology.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
